Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesCardiologySelectHealth Wireless Cardiac Monitoring Coverage …
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    DraftSelectHealthPolicy N/A

    Wireless Cardiac Monitoring (e.g., CardioMEMS) — Table of Contents entry / partial policy

    Customize your policy alerts

    Sign up for all SelectHealth policy alerts

    Know when SelectHealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Entry in SelectHealth cardiology policy set describing coverage framework and where the full wireless cardiac monitoring policy appears; affects providers seeking prior authorization and coverage guidance under SelectHealth plans.

    Policy Summary
    PayerSelectHealth
    PolicyWireless Cardiac Monitoring (e.g., CardioMEMS) — Table of Contents entry / partial policy
    Policy CodePolicy N/A
    Change TypeMaterial revisions and multiple additions (coverage criteria updates, contraindication additions, new IVL commercial indication)
    Effective DateMar 5, 2023
    Last ReviewFeb 20, 2025
    Next Review DateN/A
    Key ActionVerify member benefits and obtain prior authorization per SelectHealth policy (reference Policy #642) before scheduling device implantation or advanced procedures.
    SourceLink
    POLICY UPDATE CHANGES

    Modified title of policy (previously titled 'Carotid Artery Stenting (CAS)') and updated commercial plan coverage criteria to align with current clinical standards, including recommendation pathways via Intermountain Health Cardiovascular Clinical Provider or specified symptom/stenosis criteria.

    Added 'Unclear cardiac diagnosis' and 'Active, uncontrolled infection' as absolute contraindications to this procedure.

    For Commercial Plan Policy, added language regarding an additional qualifying option for this treatment: "Select Health covers IVL for patients undergoing percutaneous coronary intervention with stenotic and heavily calcified coronary lesions."},{

    #642policy id (Table of Contents)
    Part 1/15document part
    ≥50%symptomatic stenosis threshold
    ≥70%asymptomatic stenosis threshold
    ≤10peak VO2 poor prognosis
    >4-6absolute PVR contraindication

    Coverage Criteria and Medical Necessity

    inv-01: Coverage Criteria

    Covered when ONE of the following is met:

    Primary coverage conditions: A) Recommended by Intermountain Health Cardiovascular Clinical Provider; OR B) For other clinicians, ALL of the following stenosis criteria: symptomatic carotid artery stenosis ≥ 50% OR asymptomatic carotid artery stenosis ≥ 70%.symptomatic ≥50%; asymptomatic ≥70%

    Application depends on the member's individual benefit coverage at time of request.

    inv-02: Adult Heart Transplant Coverage (Commercial/CHIP) - Partial

    To qualify for coverage, adult candidates for transplant must meet EITHER of the following criteria (A or B):

    Approved if recommended by Intermountain Transplant Services.

    Chunk 47

    B

    Policy Summary
    PayerSelectHealth
    PolicyWireless Cardiac Monitoring (e.g., CardioMEMS) — Table of Contents entry / partial policy
    Policy CodePolicy N/A
    Change TypeMaterial revisions and multiple additions (coverage criteria updates, contraindication additions, new IVL commercial indication)
    Effective DateMar 5, 2023
    Last ReviewFeb 20, 2025
    Next Review DateN/A
    Key ActionVerify member benefits and obtain prior authorization per SelectHealth policy (reference Policy #642) before scheduling device implantation or advanced procedures.
    SourceLink
    On This Page
    Coverage Criteria and Medical NecessityProcedure and Billing CodesPrior Authorization, Documentation, and Billing ActionsBackground and ScopeDefinitions and Key Terms
  1. B1: Provided by in-network providers in an in-network facility (Idaho commercial plans may allow out-of-network benefits if all other criteria are met).

    Chunk 48

  2. B2: End-stage irreversible and progressive cardiac disease with limited life expectancy and no reasonable alternative medical or surgical therapy.

    Chunk 48

  3. B3: NYHA Class III or IV cardiac dysfunction despite maximal therapy.

    Chunk 48

  4. B4: At least one qualifying diagnosis (examples: idiopathic dilated cardiomyopathy; ischemic cardiomyopathy; valvular heart disease; myocarditis; restrictive cardiomyopathy; congenital heart disease; adriamycin cardiomyopathy; peripartum cardiomyopathy; hypertrophic cardiomyopathy; infiltrative cardiomyopathy confined to the heart; Chagas disease; unresectable primary cardiac tumor; intractable life‑threatening arrhythmias; severe chronic cardiac allograft vasculopathy).

    Chunk 49

  5. B5: When pulmonary hypertension exists, pulmonary vascular resistance ≤ 5 Wood units (with or without afterload reduction).≤ 5 Wood units

    Chunk 49

  6. B6: Reasonable expectation that post‑transplant quality of life (physical and social function) will be improved.

    Chunk 49

  7. B7: Strong patient motivation and understanding of procedure risks and lifelong follow-up.

    Chunk 49

  8. B8: Medical assessment that patient can tolerate immunosuppression and has no other major system disease precluding surgery.

    Chunk 49

  9. B9: Medical and social assessment demonstrating sufficient social stability to ensure compliance with long‑term follow-up and immunosuppressive program.

    Chunk 49

  10. B10: No uncontrolled/untreated psychiatric disorder or substance use disorder that would interfere with compliance.

    Chunk 49

  11. B11: Age at time of transplant listing: 18 and < 70 years.18 to <70 years

    Chunk 49

  12. ref

    inv-03: Transplant candidate selection

    Covered when patient selection and evaluation meet accepted clinical criteria:

    Transplant candidacy general criteria: Severe heart failure refractory to maximal medical therapy with expectation of survival benefit from transplantation; documentation of functional capacity and use of prognostic risk models (e.g., HFSS).

    Support with peak VO2 testing and validated risk models.

    Peak VO2 strata: Peak VO2 <= 10 mL/kg/min OR peak VO2 10-14 mL/kg/min with persistent poor exercise tolerance on repeated testing.<=10 mL/kg/min; 10-14 mL/kg/min requires serial measurements

    Chunks 55-56

    Contraindications assessment: No absolute contraindications such as pulmonary vascular resistance >4-6 Wood units (unless pharmacologically reducible), active infection, or active malignancy; adequate pulmonary function (e.g., FEV1 >= 1.0 L and FVC >=50% predicted).PVR thresholds and pulmonary function values

    Chunks 58 and 60